Skip to content

Sight Sciences, Inc. SGHT Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

AbbVie logo
AbbVieABBV
Schering-Plough logo
Schering-PloughSGP
Bausch + Lomb logo
Bausch + LombBLCO
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
Boston Scientific logo
Boston ScientificBSX

Other financials

Income statement

See full
Revenue$19.7M+12.5%
Gross profit$17.0M+12.5%
Operating income-$12.4M+10.4%
Net income-$13.0M+8.3%
EPS (diluted)-$0.24+14.3%

Balance sheet

See full
Cash & equivalents$85.0M-21.9%
Total debt$40.9M+1.1%
Total equity$53.9M-30.6%
Total assets$109.7M-15.4%

Cash flow

See full
Operating cash flow-$7.0M+39.4%
CapEx$60.0K
Free cash flow-$7.1M+38.9%

Valuation

See full
Market cap$294.9M+35.0%
Enterprise value$250.83M+59.0%
P/S3.7×+0.8×

Profitability

See full
Gross margin86.2%+0.5pp
Operating margin-44.8%-10.2pp
Net margin-46.8%-9.6pp
FCF margin-31.9%+0.2pp

Returns & leverage

See full
Return on equity-56.6%+4.3pp
Debt / equity0.8×+0.2×
Current ratio5.9×-4.6×

Where this comes from

Reported directly by Sight Sciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Sight Sciences, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sight Sciences, Inc.'s deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sight Sciences, Inc.'s deferred tax assets and other non-current assets?
Sight Sciences, Inc. (SGHT) reported deferred tax assets and other non-current assets of $370K in Q1 2026.
How has Sight Sciences, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
Sight Sciences, Inc.'s deferred tax assets and other non-current assets decreased by 21.6% year-over-year, from $472K to $370K.
What is the long-term trend for Sight Sciences, Inc.'s deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Sight Sciences, Inc.'s deferred tax assets and other non-current assets has grown at a 6.1% compound annual growth rate (CAGR), from $386K to $518K.